Entacapone Tablet, Film Coated
Product Images NDC 64980-722

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Entacapone (NDC 64980-722). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Entacapone 01)

Chemical structure of entacapone, showing its molecular formula with a nitrophenol group, a cyano group, and an ethyl-substituted amide moiety.*

FDA Label Image

100tb (Entacapone 200 mg 100bl)

Label for Entacapone Tablets, USP 200 mg oral film-coated tablets by Rising Pharma Holdings, Inc. The package contains 100 tablets. The label includes storage instructions, manufacturer Sunshine Lake Pharma Co., Ltd. in Guangdong, China, and distributor information for Rising Pharma Holdings, Inc. in East Brunswick, NJ. The NDC is 64980-722-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.